Alzchem Group AG (WBO:ACT1) Loans Receivable: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ACT1 Alzchem Group AG WBO:ACT1
55 GF Score
Price €158.50
GF Value €59.10
View Full Analysis

What is Alzchem Group AG Loans Receivable?

Alzchem Group AG WBO:ACT1 -4.63% 55 Loans Receivable is €0.0 Mil as of Jun. 2026. GuruFocus rates WBO:ACT1 with a GF Score™ of 55/100 and a GF Value™ of €59.10.

Alzchem Group AG's Loans Receivable for the quarter that ended in Jun. 2026 was €0.0 Mil.

Alzchem Group AG Loans Receivable Related Terms

Alzchem Group AG Loans Receivable Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG Loans Receivable Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alzchem Group AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:ACT1
55GF Score
Alzchem Group AG WBO:ACT1
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.0 Mil mean?
Alzchem Group AG (WBO:ACT1) has a Loans Receivable of €0.0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Alzchem Group AG and its competitors.
Is Alzchem Group AG's Loans Receivable too high?
Alzchem Group AG's current Loans Receivable is €0.0 Mil. Overall, Alzchem Group AG has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Loans Receivable compare to LIN and SHW?
Alzchem Group AG's Loans Receivable of €0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Chemicals company?
A good Loans Receivable depends on the Chemicals industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Loans Receivable is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (WBO:ACT1) has a current Loans Receivable of €0.0 Mil. The stock's GF Value™ is €59.10, compared to a current price of €158.50 — trading 168.2% above its estimated fair value. The current Loans Receivable is €0.0 Mil. Alzchem Group AG's overall GF Score™ is 55/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Alzchem Group AG (WBO:ACT1), the current Loans Receivable is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alzchem Group AG (WBO:ACT1) Overvalued in 2026?

Based on GuruFocus' analysis, Alzchem Group AG stock appears to be overvalued. The current stock price of €158.50 is trading 168.2% above its estimated GF Value™ of €59.10.

Key valuation signals for WBO:ACT1:

  • Loans Receivable: €0.0 Mil
  • GF Value™: €59.10 vs. price of €158.50 (168.2% above fair value)
  • GF Score™: 55/100

No single metric tells the full story. See the WBO:ACT1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
55GF Score

Get the complete analysis for WBO:ACT1

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€158.50
Price
€59.10
GF Value